nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—L-Tyrosine—Melphalan—ovarian cancer	0.471	0.585	CrCrCtD
Mimosine—L-DOPA—Melphalan—ovarian cancer	0.334	0.415	CrCrCtD
Mimosine—TYR—Dopamine metabolism—SOD1—ovarian cancer	0.011	0.094	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—SELENBP1—ovarian cancer	0.00824	0.0706	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—FOLR1—ovarian cancer	0.00584	0.0501	CbGpPWpGaD
Mimosine—CCL2—myometrium—ovarian cancer	0.00498	0.0678	CbGeAlD
Mimosine—CCL2—Folate Metabolism—FOLR1—ovarian cancer	0.00484	0.0415	CbGpPWpGaD
Mimosine—CCL2—embryo—ovarian cancer	0.00479	0.0652	CbGeAlD
Mimosine—SHMT1—uterine cervix—ovarian cancer	0.00418	0.0569	CbGeAlD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—NME2—ovarian cancer	0.00412	0.0353	CbGpPWpGaD
Mimosine—CCL2—epithelium—ovarian cancer	0.00391	0.0532	CbGeAlD
Mimosine—CCL2—uterine cervix—ovarian cancer	0.00387	0.0527	CbGeAlD
Mimosine—SHMT1—endometrium—ovarian cancer	0.00378	0.0515	CbGeAlD
Mimosine—CCL2—decidua—ovarian cancer	0.00369	0.0502	CbGeAlD
Mimosine—SHMT1—gonad—ovarian cancer	0.00351	0.0477	CbGeAlD
Mimosine—CCL2—endometrium—ovarian cancer	0.0035	0.0477	CbGeAlD
Mimosine—CCL2—ATF4 activates genes—ATF3—ovarian cancer	0.00329	0.0282	CbGpPWpGaD
Mimosine—CCL2—uterus—ovarian cancer	0.00323	0.0439	CbGeAlD
Mimosine—SHMT1—female reproductive system—ovarian cancer	0.00313	0.0426	CbGeAlD
Mimosine—SHMT1—Vincristine—Vinorelbine—ovarian cancer	0.0031	0.554	CbGdCrCtD
Mimosine—CCL2—PERK regulates gene expression—ATF3—ovarian cancer	0.003	0.0257	CbGpPWpGaD
Mimosine—SHMT1—bone marrow—ovarian cancer	0.00296	0.0402	CbGeAlD
Mimosine—TYR—lymph node—ovarian cancer	0.00296	0.0402	CbGeAlD
Mimosine—CCL2—female reproductive system—ovarian cancer	0.0029	0.0395	CbGeAlD
Mimosine—SHMT1—female gonad—ovarian cancer	0.00285	0.0388	CbGeAlD
Mimosine—SHMT1—vagina—ovarian cancer	0.00283	0.0386	CbGeAlD
Mimosine—CCL2—bone marrow—ovarian cancer	0.00274	0.0373	CbGeAlD
Mimosine—CCL2—female gonad—ovarian cancer	0.00264	0.0359	CbGeAlD
Mimosine—CCL2—vagina—ovarian cancer	0.00262	0.0357	CbGeAlD
Mimosine—SHMT1—testis—ovarian cancer	0.00253	0.0344	CbGeAlD
Mimosine—SHMT1—Vinblastine—Vinorelbine—ovarian cancer	0.00249	0.446	CbGdCrCtD
Mimosine—CCL2—testis—ovarian cancer	0.00234	0.0319	CbGeAlD
Mimosine—SHMT1—One Carbon Metabolism—TYMS—ovarian cancer	0.00214	0.0184	CbGpPWpGaD
Mimosine—SHMT1—Trans-sulfuration and one carbon metabolism—TYMS—ovarian cancer	0.00193	0.0165	CbGpPWpGaD
Mimosine—SHMT1—lymph node—ovarian cancer	0.00183	0.0249	CbGeAlD
Mimosine—CCL2—lymph node—ovarian cancer	0.0017	0.0231	CbGeAlD
Mimosine—CCL2—IL-1 signaling pathway—IKBKG—ovarian cancer	0.00161	0.0138	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—ATF3—ovarian cancer	0.00144	0.0124	CbGpPWpGaD
Mimosine—CCL2—Unfolded Protein Response (UPR)—ATF3—ovarian cancer	0.00132	0.0113	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.00121	0.0104	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—SLC2A1—ovarian cancer	0.00121	0.0103	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—SOD1—ovarian cancer	0.00119	0.0102	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—FASN—ovarian cancer	0.00118	0.0101	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—ovarian cancer	0.00112	0.00957	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.00109	0.00936	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—CCND2—ovarian cancer	0.00109	0.00932	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—SOD2—ovarian cancer	0.00107	0.00919	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—IKBKG—ovarian cancer	0.00106	0.00913	CbGpPWpGaD
Mimosine—CCL2—ATF4 activates genes—CXCL8—ovarian cancer	0.00105	0.00901	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—SOD1—ovarian cancer	0.000986	0.00845	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—MMP9—ovarian cancer	0.000983	0.00842	CbGpPWpGaD
Mimosine—CCL2—PERK regulates gene expression—CXCL8—ovarian cancer	0.000961	0.00823	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—HDAC6—ovarian cancer	0.000934	0.008	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—ovarian cancer	0.000925	0.00793	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—SOD2—ovarian cancer	0.000888	0.00761	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—BIRC5—ovarian cancer	0.000841	0.00721	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TERT—ovarian cancer	0.000815	0.00698	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—SOD1—ovarian cancer	0.000784	0.00672	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—ovarian cancer	0.000769	0.00659	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—GADD45A—ovarian cancer	0.000763	0.00654	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL2—ovarian cancer	0.000734	0.0063	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—ovarian cancer	0.000716	0.00614	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—SOD2—ovarian cancer	0.000706	0.00605	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—ovarian cancer	0.000695	0.00596	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—IL6ST—ovarian cancer	0.000692	0.00593	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—PIK3CA—ovarian cancer	0.000689	0.00591	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—CASP3—ovarian cancer	0.000665	0.0057	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—ESR1—ovarian cancer	0.000663	0.00568	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—CTNNB1—ovarian cancer	0.000641	0.00549	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MMP9—ovarian cancer	0.000628	0.00538	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.000624	0.00535	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—STAT3—ovarian cancer	0.000618	0.0053	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—STAT3—ovarian cancer	0.000618	0.0053	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—NRAS—ovarian cancer	0.000617	0.00528	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MUC16—ovarian cancer	0.000608	0.00521	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—MAPK3—ovarian cancer	0.00059	0.00506	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—MAPK1—ovarian cancer	0.000562	0.00482	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL2—ovarian cancer	0.000558	0.00478	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CXCL8—ovarian cancer	0.000552	0.00473	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MAPK3—ovarian cancer	0.000534	0.00457	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—KRAS—ovarian cancer	0.000531	0.00455	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MTOR—ovarian cancer	0.00051	0.00437	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MAPK1—ovarian cancer	0.000508	0.00435	CbGpPWpGaD
Mimosine—SHMT1—Disease—HSD17B6—ovarian cancer	0.000494	0.00423	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—PIK3CA—ovarian cancer	0.000488	0.00418	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—PIK3CA—ovarian cancer	0.000488	0.00418	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—CDKN1B—ovarian cancer	0.000478	0.0041	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—CASP3—ovarian cancer	0.000469	0.00402	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL2—ovarian cancer	0.000462	0.00396	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CXCL8—ovarian cancer	0.000461	0.00396	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MMP9—ovarian cancer	0.000457	0.00392	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—HRAS—ovarian cancer	0.000451	0.00387	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.000451	0.00386	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TLR4—ovarian cancer	0.000448	0.00384	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL2—ovarian cancer	0.000441	0.00378	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—ovarian cancer	0.000432	0.0037	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL6—ovarian cancer	0.000432	0.0037	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—MAPK3—ovarian cancer	0.00043	0.00369	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CCND1—ovarian cancer	0.00043	0.00368	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000426	0.00365	CbGpPWpGaD
Mimosine—CCL2—Unfolded Protein Response (UPR)—CXCL8—ovarian cancer	0.000423	0.00363	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MMP9—ovarian cancer	0.000417	0.00358	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—PTEN—ovarian cancer	0.000415	0.00356	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—MAPK1—ovarian cancer	0.000409	0.00351	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—VEGFA—ovarian cancer	0.000398	0.00341	CbGpPWpGaD
Mimosine—SHMT1—Disease—CHMP4C—ovarian cancer	0.000395	0.00339	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—STAT3—ovarian cancer	0.000394	0.00338	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—INHA—ovarian cancer	0.000392	0.00336	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—IL6—ovarian cancer	0.00039	0.00334	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NME2—ovarian cancer	0.000378	0.00324	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—ovarian cancer	0.000378	0.00324	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAPK3—ovarian cancer	0.000376	0.00322	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT1—ovarian cancer	0.00036	0.00308	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TP53—ovarian cancer	0.000358	0.00307	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAPK1—ovarian cancer	0.000358	0.00307	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—CASP3—ovarian cancer	0.000355	0.00304	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MYC—ovarian cancer	0.000345	0.00296	CbGpPWpGaD
Mimosine—SHMT1—Disease—BCL9—ovarian cancer	0.000342	0.00294	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—KRAS—ovarian cancer	0.000338	0.0029	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000334	0.00286	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL6—ovarian cancer	0.000328	0.00281	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—ovarian cancer	0.00031	0.00266	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CXCL8—ovarian cancer	0.000304	0.0026	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TP53—ovarian cancer	0.000301	0.00258	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—NRAS—ovarian cancer	0.000298	0.00255	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TP53—ovarian cancer	0.000297	0.00254	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CDKN1B—ovarian cancer	0.000297	0.00254	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CASP3—ovarian cancer	0.000291	0.00249	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL2—ovarian cancer	0.00029	0.00249	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—ovarian cancer	0.00029	0.00249	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—HRAS—ovarian cancer	0.000287	0.00246	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HSD17B6—ovarian cancer	0.000287	0.00246	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—MAPK3—ovarian cancer	0.000285	0.00244	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TP53—ovarian cancer	0.000283	0.00243	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CCND1—ovarian cancer	0.000283	0.00243	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—TUBB3—ovarian cancer	0.000276	0.00237	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MMP9—ovarian cancer	0.000275	0.00236	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL6—ovarian cancer	0.000272	0.00233	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—MAPK1—ovarian cancer	0.000271	0.00232	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL6—ovarian cancer	0.000259	0.00222	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—KRAS—ovarian cancer	0.000256	0.00219	CbGpPWpGaD
Mimosine—SHMT1—Disease—PPP1CC—ovarian cancer	0.000255	0.00218	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—ovarian cancer	0.000254	0.00217	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—CTNNB1—ovarian cancer	0.000247	0.00212	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYTB—ovarian cancer	0.000244	0.00209	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DLC1—ovarian cancer	0.000244	0.00209	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MAPK3—ovarian cancer	0.000233	0.002	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ATF3—ovarian cancer	0.000233	0.002	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MYC—ovarian cancer	0.000227	0.00195	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MAPK1—ovarian cancer	0.000222	0.0019	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—EGFR—ovarian cancer	0.000222	0.0019	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—HRAS—ovarian cancer	0.000218	0.00187	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL6—ovarian cancer	0.000216	0.00185	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—BRIP1—ovarian cancer	0.000213	0.00183	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPP1CC—ovarian cancer	0.000213	0.00183	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—IL6—ovarian cancer	0.000208	0.00179	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.000208	0.00178	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—MYC—ovarian cancer	0.0002	0.00172	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BCL9—ovarian cancer	0.000199	0.0017	CbGpPWpGaD
Mimosine—SHMT1—Disease—HDAC6—ovarian cancer	0.000193	0.00165	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—ovarian cancer	0.000192	0.00165	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—ovarian cancer	0.000186	0.0016	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL6—ovarian cancer	0.000171	0.00146	CbGpPWpGaD
Mimosine—SHMT1—Disease—XIAP—ovarian cancer	0.000167	0.00143	CbGpPWpGaD
Mimosine—SHMT1—Disease—SMARCA4—ovarian cancer	0.000163	0.0014	CbGpPWpGaD
Mimosine—SHMT1—Disease—EREG—ovarian cancer	0.000159	0.00136	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DOK1—ovarian cancer	0.000157	0.00135	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PPP1CC—ovarian cancer	0.000148	0.00127	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—YAP1—ovarian cancer	0.000143	0.00123	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000139	0.00119	CbGpPWpGaD
Mimosine—SHMT1—Disease—FASN—ovarian cancer	0.000139	0.00119	CbGpPWpGaD
Mimosine—SHMT1—Disease—PARP1—ovarian cancer	0.000139	0.00119	CbGpPWpGaD
Mimosine—SHMT1—Disease—SLC2A1—ovarian cancer	0.000132	0.00113	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—FASN—ovarian cancer	0.000117	0.000999	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC5A5—ovarian cancer	0.000115	0.000983	CbGpPWpGaD
Mimosine—SHMT1—Disease—PPP2R1A—ovarian cancer	0.000112	0.000963	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HDAC6—ovarian cancer	0.000112	0.000959	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC2A1—ovarian cancer	0.000111	0.000949	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PPP2R1A—ovarian cancer	0.00011	0.000946	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP1B1—ovarian cancer	0.000106	0.00091	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL8—ovarian cancer	0.000106	0.000909	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—YAP1—ovarian cancer	9.91e-05	0.000849	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—XIAP—ovarian cancer	9.7e-05	0.000832	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SMARCA4—ovarian cancer	9.46e-05	0.000811	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPP2R1A—ovarian cancer	9.41e-05	0.000807	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EREG—ovarian cancer	9.23e-05	0.000791	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MMP2—ovarian cancer	8.98e-05	0.000769	CbGpPWpGaD
Mimosine—SHMT1—Disease—TERT—ovarian cancer	8.93e-05	0.000765	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCB1—ovarian cancer	8.74e-05	0.000749	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PGR—ovarian cancer	8.65e-05	0.000741	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TYMS—ovarian cancer	8.58e-05	0.000736	CbGpPWpGaD
Mimosine—SHMT1—Disease—CAV1—ovarian cancer	8.26e-05	0.000708	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PARP1—ovarian cancer	8.04e-05	0.000689	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6ST—ovarian cancer	7.83e-05	0.000671	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6ST—ovarian cancer	7.69e-05	0.000659	CbGpPWpGaD
Mimosine—SHMT1—Disease—APC—ovarian cancer	7.52e-05	0.000645	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CXCL8—ovarian cancer	7.46e-05	0.000639	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CG—ovarian cancer	7.39e-05	0.000633	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CAV1—ovarian cancer	6.92e-05	0.000593	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CTNNB1—ovarian cancer	6.88e-05	0.00059	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CD—ovarian cancer	6.61e-05	0.000567	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PPP2R1A—ovarian cancer	6.52e-05	0.000559	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CD—ovarian cancer	6.5e-05	0.000557	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CG—ovarian cancer	6.3e-05	0.00054	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERBB2—ovarian cancer	5.84e-05	0.000501	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTOR—ovarian cancer	5.77e-05	0.000494	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CB—ovarian cancer	5.77e-05	0.000494	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CB—ovarian cancer	5.66e-05	0.000485	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CD—ovarian cancer	5.54e-05	0.000475	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL8—ovarian cancer	5.44e-05	0.000466	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDKN1B—ovarian cancer	5.41e-05	0.000464	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2—ovarian cancer	5.2e-05	0.000446	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TERT—ovarian cancer	5.18e-05	0.000444	CbGpPWpGaD
Mimosine—SHMT1—Disease—CTNNB1—ovarian cancer	5.11e-05	0.000438	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTEN—ovarian cancer	4.98e-05	0.000427	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CB—ovarian cancer	4.83e-05	0.000414	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CAV1—ovarian cancer	4.79e-05	0.000411	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ESR1—ovarian cancer	4.62e-05	0.000396	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6ST—ovarian cancer	4.54e-05	0.000389	CbGpPWpGaD
Mimosine—SHMT1—Disease—STAT3—ovarian cancer	4.46e-05	0.000382	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRAS—ovarian cancer	4.44e-05	0.000381	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APC—ovarian cancer	4.37e-05	0.000374	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CG—ovarian cancer	4.37e-05	0.000374	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NRAS—ovarian cancer	4.37e-05	0.000374	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAPK3—ovarian cancer	4.26e-05	0.000365	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAPK3—ovarian cancer	4.18e-05	0.000358	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTEN—ovarian cancer	4.17e-05	0.000358	CbGpPWpGaD
Mimosine—SHMT1—Disease—MYC—ovarian cancer	4.14e-05	0.000355	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAPK1—ovarian cancer	4.05e-05	0.000347	CbGpPWpGaD
Mimosine—SHMT1—Disease—EGFR—ovarian cancer	4.05e-05	0.000347	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAPK1—ovarian cancer	3.98e-05	0.000341	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—EGFR—ovarian cancer	3.98e-05	0.000341	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CD—ovarian cancer	3.84e-05	0.000329	CbGpPWpGaD
Mimosine—SHMT1—Disease—KRAS—ovarian cancer	3.83e-05	0.000328	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KRAS—ovarian cancer	3.76e-05	0.000322	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CA—ovarian cancer	3.51e-05	0.000301	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CA—ovarian cancer	3.45e-05	0.000296	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB2—ovarian cancer	3.39e-05	0.000291	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CB—ovarian cancer	3.35e-05	0.000287	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MTOR—ovarian cancer	3.35e-05	0.000287	CbGpPWpGaD
Mimosine—SHMT1—Disease—HRAS—ovarian cancer	3.25e-05	0.000279	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL8—ovarian cancer	3.21e-05	0.000276	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRAS—ovarian cancer	3.19e-05	0.000274	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDKN1B—ovarian cancer	3.14e-05	0.000269	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—ovarian cancer	3.11e-05	0.000267	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP3—ovarian cancer	3.08e-05	0.000264	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2—ovarian cancer	3.07e-05	0.000263	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—ovarian cancer	3.06e-05	0.000262	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCND1—ovarian cancer	2.99e-05	0.000257	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CTNNB1—ovarian cancer	2.97e-05	0.000254	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CA—ovarian cancer	2.94e-05	0.000252	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP9—ovarian cancer	2.91e-05	0.000249	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTEN—ovarian cancer	2.89e-05	0.000248	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—ovarian cancer	2.87e-05	0.000246	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—ovarian cancer	2.82e-05	0.000242	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—ovarian cancer	2.61e-05	0.000224	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT3—ovarian cancer	2.59e-05	0.000222	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRAS—ovarian cancer	2.58e-05	0.000221	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK3—ovarian cancer	2.47e-05	0.000212	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—ovarian cancer	2.4e-05	0.000206	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MYC—ovarian cancer	2.4e-05	0.000206	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK1—ovarian cancer	2.35e-05	0.000201	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EGFR—ovarian cancer	2.35e-05	0.000201	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KRAS—ovarian cancer	2.22e-05	0.00019	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CA—ovarian cancer	2.04e-05	0.000175	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—ovarian cancer	1.97e-05	0.000169	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRAS—ovarian cancer	1.89e-05	0.000162	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—ovarian cancer	1.81e-05	0.000155	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—ovarian cancer	1.67e-05	0.000143	CbGpPWpGaD
